{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:32:09Z","timestamp":1792175529267,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03747-1","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T09:54:17Z","timestamp":1748944457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An exploratory study on the application of nanopore sequencing for detecting Mycobacterium tuberculosis drug resistance in respiratory specimens"],"prefix":"10.1186","volume":"25","author":[{"given":"Niansa","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxing","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aichun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"10181","key":"3747_CR1","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"J Furin","year":"2019","unstructured":"Furin J, Cox H, Pai M, Tuberculosis. Lancet. 2019;393(10181):1642\u201356.","journal-title":"Lancet"},{"key":"3747_CR2","unstructured":"WHO, Global Tuberculosis Report. 2024 2024. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024 (accessed November 25, 2024)."},{"key":"3747_CR3","volume-title":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27\u201329 October 2020","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27\u201329 October 2020. Geneva: World Health Organization; 2021."},{"issue":"1","key":"3747_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/14656566.2021.1967930","volume":"23","author":"G Fekadu","year":"2022","unstructured":"Fekadu G, Chow DY, You JHS. The pharmacotherapeutic management of pulmonary tuberculosis: an update of the state-of-the-art. Expert Opin Pharmacother. 2022;23(1):139\u201348.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"3747_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/pathogens13010027","volume":"13","author":"K Naidoo","year":"2023","unstructured":"Naidoo K, Perumal R, Ngema SL, Shunmugam L, Somboro AM. Rapid diagnosis of Drug-Resistant Tuberculosis-Opportunities and challenges. Pathogens. 2023;13(1):27. https:\/\/doi.org\/10.3390\/pathogens13010027. Published 2023 Dec 27.","journal-title":"Pathogens"},{"issue":"1","key":"3747_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s10020-023-00743-1","volume":"29","author":"ZB Liu","year":"2023","unstructured":"Liu ZB, Cheng LP, Pan HQ, Wu XC, Lu FH, Cao J, Wang L, Wei W, Chen HY, Sha W, Sun Q. Performance of the meltpro TB assay as initial test for diagnosis of pulmonary tuberculosis with drug-resistance detection. Mol Med. 2023;29(1):153.","journal-title":"Mol Med"},{"issue":"1","key":"3747_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40249-020-00652-z","volume":"9","author":"L Wan","year":"2020","unstructured":"Wan L, et al. Accuracy of a reverse Dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China. Infect Dis Poverty. 2020;9(1):38.","journal-title":"Infect Dis Poverty"},{"issue":"8","key":"3747_CR8","first-page":"616","volume":"34","author":"CF Liu","year":"2021","unstructured":"Liu CF, et al. Evaluation of multidrug resistant Loop-mediated isothermal amplification assay for detecting the drug resistance of Mycobacterium tuberculosis. Biomed Environ Sci. 2021;34(8):616\u201322.","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"3747_CR9","first-page":"CD013694","volume":"3","author":"AE Shapiro","year":"2021","unstructured":"Shapiro AE, et al. Xpert MTB\/RIF and Xpert ultra assays for screening for pulmonary tuberculosis and RIF resistance in adults, irrespective of signs or symptoms. Cochrane Database Syst Rev. 2021;3(3):CD013694.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"3747_CR10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1473-3099(16)30067-6","volume":"16","author":"J Ho","year":"2016","unstructured":"Ho J, Nguyen PTB, Nguyen TA, Tran KH, Van Nguyen S, Nguyen NV, Nguyen HB, Luu KB, Fox GJ, Marks GB. Reassessment of the positive predictive value and specificity of Xpert MTB\/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis. Lancet Infect Dis. 2016;16(9):1045\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"3747_CR11","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1128\/JCM.02046-10","volume":"49","author":"T Luo","year":"2011","unstructured":"Luo T, Jiang L, Sun W, Fu G, Mei J, Gao Q. Multiplex real-time PCR melting curve assay to detect drug-resistant mutations of Mycobacterium tuberculosis. J Clin Microbiol. 2011;49(9):3132\u20138. https:\/\/doi.org\/10.1128\/JCM.02046-10. Epub 2011 Jul 13.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"3747_CR12","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1128\/JCM.00812-10","volume":"48","author":"MV Ramirez","year":"2010","unstructured":"Ramirez MV, Cowart KC, Campbell PJ, Morlock GP, Sikes D, Winchell JM, Posey JE. Rapid detection of multidrug-resistant Mycobacterium tuberculosis by use of real-time PCR and high-resolution melt analysis. J Clin Microbiol. 2010;48(11):4003\u20139.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"3747_CR13","doi-asserted-by":"publisher","first-page":"e0271508","DOI":"10.1371\/journal.pone.0271508","volume":"17","author":"EA Mesfin","year":"2022","unstructured":"Mesfin EA, et al. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia. PLoS ONE. 2022;17(8):e0271508.","journal-title":"PLoS ONE"},{"issue":"5","key":"3747_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/ng.811","volume":"43","author":"CB Ford","year":"2011","unstructured":"Ford CB, Lin PL, Chase MR, et al. Use of whole genome sequencing toestimate the mutation rate of Mycobacterium tuberculosis during latentinfection[1]. Nat Genet. 2011;43(5):482\u20136.","journal-title":"Nat Genet"},{"issue":"9","key":"3747_CR15","first-page":"533","volume":"17","author":"CJ Meehan","year":"2019","unstructured":"Meehan CJ, Goig GA, Kohl TA, et al. Whole genome sequencing OfMycobacterium tuberculosis: current standards and open issues1. Naturereviews Microbiol. 2019;17(9):533\u201345.","journal-title":"Naturereviews Microbiol"},{"issue":"6","key":"3747_CR16","doi-asserted-by":"publisher","first-page":"e0260522","DOI":"10.1128\/spectrum.02605-22","volume":"10","author":"SH Wu","year":"2022","unstructured":"Wu SH, et al. Development and assessment of a novel Whole-Gene-Based targeted Next-Generation sequencing assay for detecting the susceptibility of Mycobacterium tuberculosis to 14 drugs. Microbiol Spectr. 2022;10(6):e0260522.","journal-title":"Microbiol Spectr"},{"key":"3747_CR17","doi-asserted-by":"crossref","unstructured":"Miao Q, Ma Y, Wang Q et al. Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice. Clin Infect Dis. 2018;67(suppl 2):S231\u201340.","DOI":"10.1093\/cid\/ciy693"},{"issue":"11","key":"3747_CR18","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41587-021-01108-x","volume":"39","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhao Y, Bollas A, Wang Y, Au KF. Nanopore sequencing technology, bioinformatics and applications. Nat Biotechnol. 2021;39(11):1348\u201365. https:\/\/doi.org\/10.1038\/s41587-021-01108-x. Epub 2021 Nov 8.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"3747_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s10038-019-0659-4","volume":"65","author":"W Maka\u0142owski","year":"2020","unstructured":"Maka\u0142owski W, Shabardina V. Bioinformatics of nanopore sequencing. J Hum Genet. 2020;65(1):61\u20137. https:\/\/doi.org\/10.1038\/s10038-019-0659-4. Epub 2019 Aug 26.","journal-title":"J Hum Genet"},{"key":"3747_CR20","doi-asserted-by":"crossref","unstructured":"Schmidt J, Blessing F, Fimpler L, Wenzel F. Nanopore sequencing in a clinical routine laboratory: challenges and opportunities. Clin Lab. 2020;66(6).","DOI":"10.7754\/Clin.Lab.2019.191114"},{"issue":"2","key":"3747_CR21","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/S2666-5247(22)00301-9","volume":"4","author":"MB Hall","year":"2023","unstructured":"Hall MB, Rabodoarivelo MS, Koch A, Dippenaar A, George S, Grobbelaar M, et al. Evaluation of nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis. Lancet Microbe. 2023;4(2):e84\u201392.","journal-title":"Lancet Microbe"},{"issue":"1","key":"3747_CR22","doi-asserted-by":"publisher","first-page":"2078621","DOI":"10.1080\/19490976.2022.2078621","volume":"14","author":"A Benitez-Paez","year":"2022","unstructured":"Benitez-Paez A, et al. Species- and strain-level assessment using Rrn long-amplicons suggests donor\u2019s influence on gut microbial transference via fecal transplants in metabolic syndrome subjects. Gut Microbes. 2022;14(1):2078621.","journal-title":"Gut Microbes"},{"key":"3747_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijid.2022.06.001","volume":"122","author":"G Yu","year":"2022","unstructured":"Yu G, et al. Diagnostic accuracy of nanopore sequencing using respiratory specimens in the diagnosis of pulmonary tuberculosis. Int J Infect Dis. 2022;122:237\u201343.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"3747_CR24","doi-asserted-by":"publisher","first-page":"22372","DOI":"10.1038\/s41598-021-01749-7","volume":"11","author":"A Nowak","year":"2021","unstructured":"Nowak A, et al. Detection of single nucleotide and copy number variants in the Fabry disease-associated GLA gene using nanopore sequencing. Sci Rep. 2021;11(1):22372.","journal-title":"Sci Rep"},{"key":"3747_CR25","doi-asserted-by":"publisher","first-page":"7588033","DOI":"10.1155\/2022\/7588033","volume":"2022","author":"K Zhao","year":"2022","unstructured":"Zhao K, Tu C, Chen W, Liang H, Zhang W, Wang Y, Jin Y, Hu J, Sun Y, Xu J, Yu Y. Rapid identification of Drug-Resistant tuberculosis genes using direct PCR amplification and Oxford nanopore technology sequencing. Can J Infect Dis Med Microbiol. 2022;2022:7588033.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"07","key":"3747_CR26","first-page":"631","volume":"45","author":"\u5b8b\u5a9b\u5a9b,\u590f\u8f89,\u8d75\u96c1\u6797","year":"2023","unstructured":"\u5b8b\u5a9b\u5a9b,\u590f\u8f89,\u8d75\u96c1\u6797. \u7ed3\u6838\u5206\u679d\u6746\u83cc\u8868\u578b\u836f\u7269\u654f\u611f\u6027\u8bd5\u9a8c\u4e34\u754c\u6d53\u5ea6\u8bbe\u5b9a\u53d1\u5c55\u5386\u7a0b [J] \u4e2d\u56fd\u9632\u75e8\u6742\u5fd7. 2023;45(07):631\u20138.","journal-title":"\u7ed3\u6838\u5206\u679d\u6746\u83cc\u8868\u578b\u836f\u7269\u654f\u611f\u6027\u8bd5\u9a8c\u4e34\u754c\u6d53\u5ea6\u8bbe\u5b9a\u53d1\u5c55\u5386\u7a0b [J] \u4e2d\u56fd\u9632\u75e8\u6742\u5fd7"},{"key":"3747_CR27","unstructured":"\u5b59\u957f\u8d35. 2016\u5e74CLSI M100S-\u7b2c26\u7248\u6587\u4ef6\u4e3b\u8981\u66f4\u65b0\u5185\u5bb9\u89e3\u8bfb[C]\/\/ \u6d59\u6c5f\u7701\u533b\u5b66\u4f1a\u68c0\u9a8c\u533b\u5b66\u5206\u4f1a,\u6d59\u6c5f\u7701\u533b\u5e08\u534f\u4f1a\u68c0\u9a8c\u533b\u5e08\u5206\u4f1a. 2016\u5e74\u6d59\u6c5f\u7701\u68c0\u9a8c\u533b\u5b66\u5b66\u672f\u5e74\u4f1a\u8bba\u6587\u6c47\u7f16. \u89e3\u653e\u519b\u7b2c117\u533b\u9662\u68c0\u9a8c\u79d1;2016: 1."},{"issue":"11","key":"3747_CR28","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1128\/JCM.39.11.4131-4137.2001","volume":"39","author":"HH El-Hajj","year":"2001","unstructured":"El-Hajj HH, Marras SA, Tyagi S, Kramer FR, Alland D. Detection of Rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol. 2001;39(11):4131\u20137.","journal-title":"J Clin Microbiol"},{"key":"3747_CR29","first-page":"19","volume":"336","author":"RJ Pryor","year":"2006","unstructured":"Pryor RJ, Wittwer CT. Real-time polymerase chain reaction and melting curve analysis. Methods Mol Biol. 2006;336:19\u201332.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"3747_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s40291-023-00669-8","volume":"27","author":"J Chen","year":"2023","unstructured":"Chen J, Xu F. Application of nanopore sequencing in the diagnosis and treatment of pulmonary infections. Mol Diagn Ther. 2023;27(6):685\u2013701.","journal-title":"Mol Diagn Ther"},{"issue":"6","key":"3747_CR31","doi-asserted-by":"publisher","first-page":"1701354","DOI":"10.1183\/13993003.01354-2017","volume":"50","author":"P Miotto","year":"2017","unstructured":"Miotto P, et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J. 2017;50(6):1701354.","journal-title":"Eur Respir J"},{"key":"3747_CR32","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3389\/fmicb.2019.01741","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen X, et al. Evaluation of Whole-Genome sequence method to diagnose resistance of 13 Anti-tuberculosis drugs and characterize resistance genes in clinical Multi-Drug resistance Mycobacterium tuberculosis isolates from China. Front Microbiol. 2019;10:1741.","journal-title":"Front Microbiol"},{"issue":"10","key":"3747_CR33","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1021\/acs.accounts.0c00878","volume":"54","author":"V Singh","year":"2021","unstructured":"Singh V, Chibale K. Strategies to combat Multi-Drug resistance in tuberculosis. Acc Chem Res. 2021;54(10):2361\u201376.","journal-title":"Acc Chem Res"},{"issue":"6","key":"3747_CR34","doi-asserted-by":"publisher","first-page":"e20343","DOI":"10.1371\/journal.pone.0020343","volume":"6","author":"Y Yang","year":"2011","unstructured":"Yang Y, et al. Prevalence of drug-resistant tuberculosis in Mainland China: systematic review and meta-analysis. PLoS ONE. 2011;6(6):e20343.","journal-title":"PLoS ONE"},{"issue":"12","key":"3747_CR35","first-page":"000740","volume":"7","author":"C Mariner-Llicer","year":"2021","unstructured":"Mariner-Llicer C, Goig GA, Zaragoza-Infante L, Torres-Puente M, Villamayor L, Navarro D, Borras R, Chiner-Oms \u00c1, Comas I. Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes. Microb Genom. 2021;7(12):000740.","journal-title":"Microb Genom"},{"issue":"1","key":"3747_CR36","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s13104-020-05287-9","volume":"13","author":"WS Chan","year":"2020","unstructured":"Chan WS, Au CH, Chung Y, Leung HCM, Ho DN, Wong EYL, Lam TW, Chan TL, Ma ESK, Tang BSF. Rapid and economical drug resistance profiling with nanopore minion for clinical specimens with low bacillary burden of Mycobacterium tuberculosis. BMC Res Notes. 2020;13(1):444.","journal-title":"BMC Res Notes"},{"key":"3747_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jiph.2018.04.005","volume":"11","author":"MT Zaw","year":"2018","unstructured":"Zaw MT, Emran NA, Lin Z. Mutations inside rifampicin-resistance determining region of RpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis. J Infect Public Health. 2018;11:605\u201310.","journal-title":"J Infect Public Health"},{"issue":"3","key":"3747_CR38","doi-asserted-by":"publisher","first-page":"e0061021","DOI":"10.1128\/Spectrum.00610-21","volume":"9","author":"HD Gliddon","year":"2021","unstructured":"Gliddon HD, Frampton D, Munsamy V, Heaney J, Pataillot-Meakin T, Nastouli E, Pym AS, Steyn AJC, Pillay D, McKendry RA. A rapid drug resistance genotyping workflow for Mycobacterium tuberculosis, using targeted isothermal amplification and nanopore sequencing. Microbiol Spectr. 2021;9(3):e0061021.","journal-title":"Microbiol Spectr"},{"key":"3747_CR39","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H. WHO\u2019s new end TB strategy. Lancet. 2015;385:1799\u2013801. https:\/\/doi.org\/10.1016\/S0140-6736(15)60570-0.","journal-title":"Lancet"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03747-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T09:54:23Z","timestamp":1748944463000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03747-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3747"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03747-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved on February10, 2023, by the Human Research Ethics Committee of the Fourth People\u2019s Hospital of Nanning City, Guangxi Zhuang Autonomous Region (opinion number [2023]24). All research participants or their legal guardians have obtained informed consent. All methods were carried out in accordance with relevant guidelines and regulations that is Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}